Phoenix DX ^Company

Phoenix DX is an ultra-rapid point-of-care (POC) molecular diagnostics company. Phoenix DX is developing a proprietary ultra-rapid POC diagnostic that will initially test for infectious diseases of the respiratory tract. The novel platform combines for the first time DNA extraction, amplification, and detection into a single step, resulting in a potentially faster test turn around, lower costs, and higher diagnostic accuracy. This will empower clinicians and provide vulnerable patients with the immediate reassurance that they deserve and expect. Phoenix DX creates a network in which repeated testing of patients at the point of care builds up a digital map of pathogens that could track disease outbreaks and make prescribing personal and targeted.